Biogen Inc. (BIIB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 198.21 |
| Open | 198.13 |
| Bid | 187.52 x 100 |
| Ask | 197.59 x 100 |
| Day's range | 196.87 - 199.78 |
| 52-week range | 189.44 - 269.43 |
| Volume | |
| Avg. volume | 980,150 |
| Market cap | 28.781B |
| Beta (5Y monthly) | -0.06 |
| PE ratio (TTM) | 24.95 |
| EPS (TTM) | 7.92 |
| Earnings date | 06 Nov 2024 - 11 Nov 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 269.61 |
ZacksHere's Why Biogen Inc. (BIIB) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Barrons.comHealthcare Stocks Have Popped. Consider These 2 That Haven’t.
Healthcare stocks have jumped into pricey territory. The exchange-traded fund, home to health insurers, pharmaceuticals and medical device makers, has gained 6% to $155 from a low point in early August. Money has poured into the sector as markets have grown concerned about the economy, particularly with growth slowing in retail and manufacturing.
Investor's Business DailyIs Eli Lilly Stock A Buy After Slashing The Price Of Its New Weight-Loss Drug?
Eli Lilly halved the price of a new version of its weight-loss drug, Zepbound. Is Eli Lilly stock a buy right now?
© 2024 Yahoo. All rights reserved.